Talis Biomedical Operating Income

Talis Biomedical (TLIS) currently reports a operating income of $-49M as of June 2024. That compares with $-90M in the prior-year period — up 45.5% year over year. Use the charts on this page to explore Talis Biomedical's operating income history and peer comparisons.

Talis Biomedical's operating income increased from $-90M to $-49M — a 45.5% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Talis Biomedical reported $-49M in operating income as of June 2024. That compares with $-90M in the prior-year period — up 45.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-49M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Talis Biomedical, and consider following TLIS for alerts when major investors trade the stock.

Talis Biomedical is classified in the Healthcare sector. On operating income, it currently shows $-49M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLIS with unrelated industries.